China patent for LabTech
Tuesday, 16 September, 2008
LabTech Systems [ASX: LBT] has been granted a Chinese design patent for the company's MicroStreak applicator.
The patent, known in China as a Certificate of Registration, was granted by the Chinese Patent Office.
It is the first patent to be granted based in the technologies which together comprise the applicator, but other patents are pending.
LabTech recently received milestone payments of $1.74 million – the first milestone payments from the project - from bioMerieux, as recognition of LabTech's progress with the applicator.
Multiple myeloma treatment reprograms patients' own immune cells
An Australian and Victorian Government funding agreement has allowed eligible Australians with...
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
